Opinion |Indian pharma at the crossroads as US cracks the whip
Companies rarely accept wrongdoing until they are presented with incontrovertible evidence
There are very few industries as notorious as Big Pharma. Fewer still have done more to deserve that notoriety. Tweaking existing drugs to generate new patents, price gouging by creating artificial scarcities, and simply buying off competitors, there’s hardly a dirty trick that pharma companies haven’t tried.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more